title: Clinical significance of gene-diagnosis for defects in coagulation factors and inhibitors.
abstract: cDNA sequences of all known coagulation factors and inhibitors of coagulation have been described and an enormous number of disease generating mutations in these factors has been found by genetic analysis of affected families. The vast majority of these defects have severe clinical consequences such as spontaneous bleeding or predisposition to venous thrombosis and pulmonary embolism. While all the genetic defects described so far cause disease, or at least represent a risk factor for diseases such as bleeding or thrombosis, only a minority of these conditions actually need DNA analysis to be detected and/or treated properly. The purpose of this review is therefore to describe clinical situations in which the knowledge of the underlying genetic defect is important for decision making in patients with inherited hemophilia or thrombophilia.
mesh_terms: D000293:Adolescent; D000328:Adult; D000925:Anticoagulants / Q000009:adverse effects / Q000627:therapeutic use; D001779:Blood Coagulation Factors / Q000037:antagonists & inhibitors* / Q000235:genetics*; D002648:Child; D018076:DNA, Complementary / Q000032:analysis; D005091:Exons; D005164:Factor IX / Q000235:genetics; D005165:Factor V / Q000235:genetics; D005169:Factor VIII / Q000235:genetics; D005176:Factor XIII / Q000235:genetics; D005260:Female; D005340:Fibrinogen / Q000235:genetics; D008040:Genetic Linkage; D020022:Genetic Predisposition to Disease; D005821:Genetic Techniques; D006467:Hemophilia A / Q000175:diagnosis / Q000235:genetics*; D002836:Hemophilia B / Q000175:diagnosis / Q000235:genetics*; D006470:Hemorrhage / Q000139:chemically induced / Q000235:genetics; D006720:Homozygote; D006801:Humans; D007438:Introns; D016015:Logistic Models; D008297:Male; D009154:Mutation; D016017:Odds Ratio; D017354:Point Mutation; D011110:Polymorphism, Genetic; D011247:Pregnancy; D011296:Prenatal Diagnosis; D011655:Pulmonary Embolism / Q000235:genetics / Q000517:prevention & control; D012307:Risk Factors; D019851:Thrombophilia / Q000175:diagnosis / Q000235:genetics*; D013927:Thrombosis / Q000235:genetics / Q000517:prevention & control; D020246:Venous Thrombosis / Q000235:genetics / Q000517:prevention & control
chemical_list: D000925:Anticoagulants; D001779:Blood Coagulation Factors; D018076:DNA, Complementary; C064567:factor IX Leyden; D005165:Factor V; D005169:Factor VIII; D005164:Factor IX; D005340:Fibrinogen; D005176:Factor XIII